Trials / Completed
CompletedNCT02633670
Hemopatch Versus No Hemopatch (Renal Transplant)
A Prospective Randomized Trial of Hemopatch Versus No Hemopatch For the Intraoperative Hemostasis During Deceased Donor Renal Transplant
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- St. Joseph's Healthcare Hamilton · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Kidney transplantation remains one of the most common organ transplanted today but the surgical technique has changed very little from the original pelvic operation. The deceased donor renal transplant poses a particular challenge to the surgeon due to lack of detailed pre operative vascular assessment. The hemopatch is a promising new sealing synthetic hemostatIc agent with a novel dual mechanism of action that is more convenient to apply rather then using other hemostatic agents, which require warming and/or mixing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hemopatch | |
| DEVICE | No Hemopatch |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2015-12-17
- Last updated
- 2021-12-16
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02633670. Inclusion in this directory is not an endorsement.